LIFUS-driven engineered bacteria reprogram immunosuppressive niches via mechano-NOTCH signaling.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41806839.
- Also identified by DOI 10.1016/j.xcrm.2026.102658 and PMC identifier 13006435.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Solid tumors impose coupled stromal and immunologic barriers that limit T cell infiltration and function. Here, we engineer Salmonella VNP20009 to express gas vesicles (GVs), creating an intratumoral cavitation source that converts low-intensity focused ultrasound (LIFUS) into localized mechanical forces. LIFUS-activated GVs remodel the tumor microenvironment by reducing cancer-associated fibroblast (CAF) abundance, decompressing the matrix, and selectively disrupting CAF-CD8<sup>+</sup> T cell communication via a mechanosensitive Notch1-Jagged1 axis. Single-cell RNA sequencing reveals a redistribution of CD8<sup>+</sup> T cell states, characterized by enrichment of cytotoxic effector populations and attenuation of NOTCH signaling in memory-associated cells. These biomechanical changes enhance intratumoral CD8<sup>+</sup> T cell infiltration and restore effector cytokine production. Leveraging this mechanism, we develop a mechano-priming approach for adoptive T cell therapies. Pre-conditioning with LIFUS-driven GVs improves CD8<sup>+</sup> T cell cytotoxicity, strengthens tumor cell adhesion, reduces exhaustion signatures, and achieves durable tumor control and extended survival in orthotopic and metastatic models.
Medical subject headings
- Receptors, Notch
- Salmonella
- Ultrasonic Waves